Nuclear Regulatory Commission February 15, 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
NUREG-1556, Volume 9, Revision 2, “Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses”
The Nuclear Regulatory Commission (NRC) is announcing the completion and availability of NUREG-1556, Volume 9, Revision 2, ``Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses,'' dated January 2008.
Independent External Review Panel To Identify Vulnerabilities in the U.S. Nuclear Regulatory Commission's Materials Licensing Program; Meeting Notice
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Independent External Review Panel to Identify Vulnerabilities in the NRC's Materials Licensing Program on March 5 through 7, 2008. A copy of the agenda for the meeting can be obtained by e-mailing Mr. Aaron T. McCraw at the contact information below. Purpose: To initiate the Panel's discussions and deliberations in developing their final report and to allow members of the public an opportunity to provide comments to the Panel on its draft report. The Panel's draft report is located in the NRC's Agencywide Document Access and Management System (ADAMS) using Accession Number ML080230554. Date and Time for Closed Sessions: There will be no closed sessions during this meeting. Date and Time for Open Session: March 5, 2008, from 2 p.m. to 4:30 p.m.; March 6, 2008, from 9 a.m. to 4:30 p.m.; and March 7, 2008, from 9 a.m. to 12 p.m. Address for Public Meeting: NRC, Two White Flint North Building, 11545 Rockville Pike, Rockville, Maryland 20852. Specific room locations will be indicated on the agenda. Public Participation: Any member of the public who wishes to participate in the meeting should contact Mr. McCraw using the information below. Contact Information: Aaron T. McCraw, e-mail: atm@nrc.gov, telephone: (301) 415-1277.
Medical Use of Byproduct Material-Amendments/Medical Event Definitions
The Nuclear Regulatory Commission (NRC) is making available preliminary draft rule language to amend its regulations concerning medical use of byproduct material. The goal of this rulemaking is to better define medical events arising from permanent implant brachytherapy procedures. The proposed amendments will change the criteria for defining a medical event for permanent implant brachytherapy from dose based to activity based, will add a requirement to report as a medical event any administration requiring a written directive if a written directive was not prepared, and will make certain administrative and clarification changes. The availability of the preliminary draft rule language is intended to inform stakeholders of the current status of the NRC's activities and solicit public comments on the information at this time. Comments may be provided as indicated under the ADDRESSES heading. The NRC may post updates periodically under Docket NRC-2008-0071 on the Federal eRulemaking Portal at https://www.regulations.gov that may be of interest to stakeholders.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
